Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs | BioSpace
Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs | BioSpace BigHat's antibody design platform integrates a high-speed characterization with AI and machine learning technologies to engineer antibodies that … Link to Full Article: Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs | BioSpace